Latest Strategy Changes News

Page 50 of 1114
SkyCity Entertainment Group posted a solid half-year profit increase to NZD 12.1 million despite a slight revenue dip, bolstered by a major equity raise and a clean bill on its Adelaide casino licence.
Victor Sage
Victor Sage
19 Feb 2026
Auckland International Airport reported a 6% rise in underlying profit for the first half of FY26, driven by passenger growth and key infrastructure projects. The airport also narrowed its full-year guidance while navigating global fleet capacity challenges.
Victor Sage
Victor Sage
19 Feb 2026
Spheria Emerging Companies Limited has reported a solid 16.8% increase in profit after tax for the half-year ending December 2025, alongside a strategic shift introducing monthly fully franked dividends.
Claire Turing
Claire Turing
18 Feb 2026
MEC Resources Ltd reported a half-year loss of $431,971 amid ongoing legal challenges over key gas exploration permits, while progressing investments in clean energy and neurotechnology. The company also completed a $359K options placement, reinforcing its financial position.
Maxwell Dee
Maxwell Dee
18 Feb 2026
Infragreen Group Limited reports a remarkable turnaround with a statutory net profit of A$3.64 million for H1 2025 and declares its inaugural interim dividend, underscoring confidence in its sustainable infrastructure investments.
Nora Hopper
Nora Hopper
18 Feb 2026
InvestSMART Group Ltd reports a solid half-year performance with funds under management reaching $750 million and a growing subscriber base, while outlining plans to enhance its digital wealth platform with AI and new services.
Claire Turing
Claire Turing
18 Feb 2026
Austco Healthcare has reported a robust first half of 2026, with revenue surging 31% and EBITDA jumping 60%, underpinned by solid contract backlog and debt-free balance sheet.
Ada Torres
Ada Torres
18 Feb 2026
IGNITE Limited reports a challenging first half of FY26 with an 18% revenue decline and a halving of statutory profit, yet maintains a fully franked interim dividend amid a strategic business closure.
Victor Sage
Victor Sage
18 Feb 2026
Nyrada Inc. reported a $3.19 million loss for the half-year ending December 2025, while advancing its lead drug candidate Xolatryp® into Phase IIa clinical trials targeting heart attack treatment.
Ada Torres
Ada Torres
18 Feb 2026
Knosys Limited reported a 4.6% revenue increase to $5.07 million for the half-year ending December 2025, driven by stronger licence and project fees. However, the company’s net loss widened significantly to $1.53 million, reflecting heavy investment in its next-generation Libero X library management system.
Sophie Babbage
Sophie Babbage
18 Feb 2026
PathKey.AI Ltd has responded to ASX inquiries about a recent spike in its share price and trading volume, confirming no undisclosed information is driving the market activity. The company points to its recent strategic update and funding completion as context for investor interest.
Sophie Babbage
Sophie Babbage
18 Feb 2026
Sports Entertainment Group reports a robust first half FY26 with nearly doubling EBITDA and declares special dividends following asset sales.
Victor Sage
Victor Sage
18 Feb 2026